Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
MR-139 by Viatris for Blepharitis: Likelihood of Approval
MR-139 is under clinical development by Viatris and currently in Phase III for Blepharitis. According to GlobalData, Phase III drugs...